|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
121,380,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
2,187 |
2,187 |
2,187 |
98,220 |
Total Buy Value |
$38,963 |
$38,963 |
$38,963 |
$2,585,297 |
Total People Bought |
1 |
1 |
1 |
2 |
Total Buy Transactions |
1 |
1 |
1 |
4 |
Total Shares Sold |
100 |
200 |
8,325 |
31,716 |
Total Sell Value |
$2,787 |
$4,692 |
$233,035 |
$1,293,892 |
Total People Sold |
1 |
1 |
2 |
3 |
Total Sell Transactions |
1 |
2 |
6 |
12 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Freeman Chris |
Chief Commercial Officer |
|
2022-06-15 |
4 |
D |
$38.42 |
$64,853 |
D/D |
(1,688) |
3,191 |
|
- |
|
Freeman Chris |
Chief Commercial Officer |
|
2022-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,879 |
4,879 |
|
- |
|
Gadde Vijaya |
Director |
|
2022-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,814 |
6,517 |
|
- |
|
Meresman Stanley J |
Director |
|
2022-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,814 |
5,873 |
|
- |
|
Kaul Samir |
Director |
|
2022-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,814 |
5,873 |
|
- |
|
Clark Ian T |
Director |
|
2022-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,198 |
2,198 |
|
- |
|
Eagle Craig |
CHIEF MEDICAL OFFICER |
|
2022-05-15 |
4 |
D |
$35.91 |
$46,180 |
D/D |
(1,286) |
2,431 |
|
- |
|
Eagle Craig |
CHIEF MEDICAL OFFICER |
|
2022-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,717 |
3,717 |
|
- |
|
Kalia Kumud |
Chief Information OfficerOffic |
|
2022-05-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
3,904 |
|
- |
|
Merrill Amelia |
SVP, PeopleOfficer |
|
2022-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,208 |
|
- |
|
Kalia Kumud |
Chief Information OfficerOffic |
|
2022-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,530 |
|
- |
|
Saia John G. |
See Remarks |
|
2022-04-15 |
4 |
D |
$71.99 |
$79,333 |
D/D |
(1,102) |
13,291 |
|
- |
|
Meresman Stanley J |
Director |
|
2022-03-10 |
4 |
AS |
$58.74 |
$289,823 |
D/D |
(4,934) |
4,059 |
|
- |
|
Meresman Stanley J |
Director |
|
2022-03-10 |
4 |
OE |
$5.94 |
$29,308 |
D/D |
4,934 |
8,993 |
|
- |
|
Meresman Stanley J |
Director |
|
2022-02-10 |
4 |
AS |
$73.80 |
$364,129 |
D/D |
(4,934) |
4,059 |
|
- |
|
Meresman Stanley J |
Director |
|
2022-02-10 |
4 |
OE |
$5.94 |
$29,308 |
D/D |
4,934 |
8,993 |
|
- |
|
Bell Michael Brian |
CHIEF FINANCIAL OFFICER |
|
2022-01-15 |
4 |
D |
$77.58 |
$96,665 |
D/D |
(1,246) |
2,062 |
|
- |
|
Bell Michael Brian |
CHIEF FINANCIAL OFFICER |
|
2022-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,308 |
3,308 |
|
- |
|
Meresman Stanley J |
Director |
|
2022-01-10 |
4 |
AS |
$86.08 |
$424,719 |
D/D |
(4,934) |
4,059 |
|
- |
|
Meresman Stanley J |
Director |
|
2022-01-10 |
4 |
OE |
$5.94 |
$29,308 |
D/D |
4,934 |
8,993 |
|
- |
|
Meresman Stanley J |
Director |
|
2021-12-10 |
4 |
AS |
$95.59 |
$471,641 |
D/D |
(4,934) |
4,059 |
|
- |
|
Meresman Stanley J |
Director |
|
2021-12-10 |
4 |
OE |
$5.94 |
$29,308 |
D/D |
4,934 |
8,993 |
|
- |
|
Meresman Stanley J |
Director |
|
2021-11-10 |
4 |
AS |
$106.38 |
$524,879 |
D/D |
(4,934) |
4,059 |
|
- |
|
Meresman Stanley J |
Director |
|
2021-11-10 |
4 |
OE |
$5.94 |
$29,308 |
D/D |
4,934 |
8,993 |
|
- |
|
Meresman Stanley J |
Director |
|
2021-10-11 |
4 |
AS |
$103.59 |
$511,113 |
D/D |
(4,934) |
4,059 |
|
- |
|
681 Records found
|
|
Page 10 of 28 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|